Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 3
1(20.0%)
Phase 1
1(20.0%)
5Total
N/A(3)
Phase 3(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03757377Not ApplicableUnknown

Moderato System in Patients With Hypertension

Role: collaborator

NCT02837445Not ApplicableUnknown

Moderato System: A Double-Blind Randomized Trial Ver 1.1

Role: collaborator

NCT03077048Phase 1Completed

Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients

Role: collaborator

NCT02282033Not ApplicableCompleted

Safety and Performance Study of the Moderato System

Role: collaborator

NCT02376075Phase 3Completed

Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albuminuria

Role: collaborator

All 5 trials loaded